Efficacy and safety of saxagliptin 5 mg once-daily therapy in elderly patients with type 2 diabetes mellitus

被引：0
|
作者：
Maheux, P. [1 ]
Doucet, J. [2 ]
Allen, E. [3 ]
Ravichandran, S. [3 ]
Harris, S.
Chen, R. [3 ]
Brulle, C. [4 ]
机构：
[1] AstraZeneca ISMO Europe, Brussels, Belgium
[2] CHU Rouen, Rouen, France
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb EMEA, Paris, France
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus
    Hollander, Priscilla L.
    Li, Jia
    Frederich, Robert
    Allen, Elsie
    Chen, Roland
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 125 - 135
  • [32] Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan
    Seino, Yutaka
    Yabe, Daisuke
    Takami, Akane
    Niemoeller, Elisabeth
    Takagi, Hiroki
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (08) : 1304 - 1309
  • [33] Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus (vol 2, pg 16, 2010)
    Levy, Juliana
    Cobas, Roberta A.
    Gomes, Marilia B.
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
  • [34] Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Pamporis, Konstantinos
    Popovic, Djordje S.
    Stachteas, Panagiotis
    Bougioukas, Konstantinos I.
    Fragakis, Nikolaos
    Rizzo, Manfredi
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3648 - 3661
  • [35] Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
    Kumar, S.
    Jang, H. C.
    Demirag, N. G.
    Skjoth, T. V.
    Endahl, L.
    Bode, B.
    DIABETIC MEDICINE, 2017, 34 (02) : 180 - 188
  • [36] A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg
    Seino, Yutaka
    Miyoshi, Hideaki
    Traberg, Heidrun Bosch
    Divyalasya, T. V. S.
    Nishijima, Keiji
    Terauchi, Yasuo
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (08) : 1321 - 1329
  • [37] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [38] Safety, tolerability, pharmacokinetics and pharmacodynamics of once-daily oral doses of saxagliptin for 2 weeks in type 2 diabetic and healthy subjects
    Boulton, David W.
    Geraldes, Margarida
    DIABETES, 2007, 56 : A161 - A161
  • [39] Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
    Perl, Shira
    Cook, William
    Wei, Cheryl
    Iqbal, Nayyar
    Hirshberg, Boaz
    DIABETES THERAPY, 2016, 7 (03) : 527 - 535
  • [40] The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.
    Chiasson, JL
    Josse, RG
    Dorman, JM
    Gerstein, HC
    Lau, D
    Leiter, LA
    Maheux, P
    Meneilly, GS
    Murphy, L
    Rodger, NW
    Ross, SA
    Ryan, E
    Yale, JF
    Wolever, TMS
    Haller, T
    Elias, I
    DIABETOLOGIA, 1999, 42 : A223 - A223
12345